In health care, patients are often left alone with their therapies. Currently, we see service and marketing in health care efforts using the internet to fill the patients’ most obvious needs. Information services, indication backgrounds, drug information, patient stories, communities around peers, compliance guidelines are all services brought to the patient on a one-to-one basis.
From a health care perspective
The Twitter #hcsmeu group, “Hcsmeu” for Health care and social media in Europe founded by Andrew Spong and Silja Chouquet is really growing and evolving in something great. Something that will be capable of moving people and things. There’s the cause and mission statement too …. and it surely is one to have. Refer to STweM for an integrative overview of what has been done meanwhile.
Now we, yes I’m one of
Onward to Telecardiology?
Telecardiology – an experimental case?
Background.
Recently, I focused on the developments in the technology of implantable pacemakers and defibrillators (http://bit.ly/8VRkZP [1]) .
I did so in the course of a consult to one of the affiliates of the cardiac devices industry in the Netherlands. I was asked to think along in the further development of cardiological care around these d
Are internet and health care authorities opposing strengths?
True, a lot of nonsense may go round through the internet channels. And surely it is a challenge to health care authorities to cope with that. As a constituency you do want the people to be rightly informed.
The Minister of Health in the Netherlands, dr. Ab Klink, has perceived himself as standing at the dilemma to intervene in information going round c
What you may like to prevent just by using social media in health care.
Here’s a Dutch father complaining about the reimbursement of a continuous glucose monitoring system in a national newspaper.
http://bit.ly/ocdca.
For the control of his daughter’s diabetes, who has also a Down syndrome, he is only reimbursed for a normal glucose meter, not the wished for continuous glucose monitoring system. (Compare the
Already we are at the third meeting of Silja Chouquet’s (#whydotpharma) and Andrew Spong’s (#andrewspong) initiative on #hscmeu.[1]
Now less people participated but, still, as it seems to me with in-depth discussions.[2] Anyway, great to see the embedded insights! All people interested submit themselves to http://is.gd/2mivy ! That ‘ll give a good overview.
Now, the next three questions from http://ow.ly/jUbv
Silja Chouquet’s (#whydotpharma) and Andrew Spong’s (#andrewspong), initiative to do a tweetup on social media in health care and pharma in Europe, had its second tweetup on August 14th.
At both meetings, about 40 people participated. So, more promotion has to be done, e.g. to “sell” it #hcsm . By the way, all people interested submit themselves to http://is.gd/2mivy . That ‘ll give a good overview.
Si
Thanks to Silja Chouquet (@whydotpharma) and Andrew Spong (@andrewspong), “twitters” on the internet interested in social media in health care and pharma, had a first Tweet up on this issue at the twitter site #hcsmeu, friday august 7th .
In a first reflection on this virtual gathering, (http://bit.ly/1m61I3) Andrew Spong, already noted the presence of people from France, Spain, Italy, Germany, Portugal, Switze
Value Innovation in medical and life sciences..
Health Care around the world is in transition.
We need better health for less costs…
Pharmaceutical and Life sciences are in transition.
We need a change of business model to master future opportunities..
To do so, needs support of people who know what the business of health care, pharmaceutics, medical and life sciences is all about, now and more precisely in the
